Underrecognition and undertreatment of atherothrombotic diseases: REACH registry Taiwan baseline data

Journal of the Formosan Medical Association

Volumn 106, Issue 7, 2007, Pages 548-557

  Cheng, Tain Junn ^a   Hsieh, Yuan Kai ^b   Ryu, Shan Jin ^c   Lai, Wen Ter ^d   Lo, Huei Ming ^e   Sung, Mao Lin ^f   Tsao, Wen Long ^g   Yip, Ping Keung ^h   Liau, Chiau Suong ^h  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Kaohsiung Medical Center   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f St Martin De Porres Hospital   (Taiwan)

^g BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^h NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atherothrombosis; Cardiovascular disease; Cerebrovascular disease; Peripheral artery disease; REACH Registry

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE REGISTRY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; OUTPATIENT; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; TAIWAN; THROMBOSIS;

EID: 34547891523     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(07)60005-9     Document Type: Article

References (31)

1. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherosclerosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004;25:1197-207.
2. Libby P. The interface of atherosclerosis and thrombosis: basic mechanisms. Vasc Med 1998;3:225-9.
3. Ohman EM, Bhatt DL, Steg PG, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events - study design: Am Heart J 2006;151:786.e1-10.
4. World Health Organisation. Reducing Risks, Promoting Healthy Life. The World Health Report. 2002. Geneva: WHO.
5. Vasan RS, Massaro JM, Wilson PWF, et al. Antecedent blood pressure and risk of cardiovascular disease; the Framingham heart study. Circulation 2002;105:48-53.
6. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295: 180-9.
7. Department of Health, Executive Yuan, Taiwan, R.O.C. Causes of Death Statistics, 1994-2005. Available from www.doh.gov.tw/statistics/ index.htm [Date accessed: August 18, 2006]
8. Yusuf S, Reddy S, Ôunpuu S, et al. Global burden of cardiovascular disease, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-53.
9. Yusuf S, Reddy S, Ôunpuu S, et al. Global burden of cardiovascular diseases part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104:2855-64.
10. Pais P, Pogue J, Gerstein H, et al. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 1996;348:358-63.
11. Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-52.
12. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischemic heart disease: an evaluation of the evidence. BMJ 1997;315:973-80.
13. Yamagishi K, Iso H, Kitamura A, et al. Smoking raises the risk of total and ischemic strokes in hypertensive men. Hypertens Res 2003;26:209-17.
14. Willigendael EM, Teijink JAW, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004;40:1158-65.
15. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-52.
16. Asia Pacific Cohort Studies Collaboration. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol 2005;34: 1036-45.
17. Bureau of Health Promotion, Department of Health, Taiwan, ROC. Taiwan Tobacco Control Annual Report, 2006. Taipei: Bureau of Health Promotion, Department of Health, Taiwan, ROC, June 8, 2006.
18. Woo KS, Yip TWC, Kwong SK, et al. Commentary: smoking and atherosclerotic diseases in Asia - the implication in global atherosclerosis prevention. Int J Epidemiol 2005; 34:1045-6.
19. Mcgee DL, The diverse populations collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observation studies. Ann Epidemiol 2005;15:87-97.
20. Wilson PWF, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162: 1867-72.
21. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006;26: 968-76.
22. Ko GTC, Chan JCN, Cockram CS, et al. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999;23:1136-42.
23. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22: 1164-71.
24. World Health Organisation. Obesity: Preventing and Managing the Global Epidemic. Report on a WHO Consultation on Obesity, Geneua, 3-5 June 1997. Geneva: WHO/NUT/NCD/98.1,1998.
25. World Health Organisation. Physical Status: The Use and Interpretation of Anthropometry. Geneva: WHO, 1995, Technical Report Series 854.
26. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham offspring study. Am Heart J 2002;143: 961-5.
27. Criqui MH, Fronek A, Rarrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-5.
28. Hirsch AT, Criqui MH, Diane TJ, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
29. Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989;30:50-7.
30. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
31. Froehlich JB, Mukherjee D, Avezum A, et al. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The global registry of acute coronary events (GRACE). Am Heart J 2006;151:1123-8.